Profil
Younok Dumortier Shin served as Vice President & Managing Director at Dermelix Biotherapeutics, LLC.
She was also the Chief Technology Officer at Avalo Therapeutics, Inc. from 2020 to 2022.
She holds a graduate and doctorate degree from McGill University, an MBA from Babson College, and an undergraduate degree from the University of British Columbia.
Anciens postes connus de Younok Dumortier Shin
| Sociétés | Poste | Fin |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2022 |
Dermelix Biotherapeutics, Llc
Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Operates as a non-clinical stage biopharmaceutical company focused on delivering treatments to patients suffering from rare genetic skin diseases | Corporate Officer/Principal | - |
Formation de Younok Dumortier Shin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Dermelix Biotherapeutics, Llc
Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Operates as a non-clinical stage biopharmaceutical company focused on delivering treatments to patients suffering from rare genetic skin diseases | Commercial Services |
















